News
Oral SERD camizestrant prolongs PFS vs. fulvestrant in breast cancer
The investigational selective estrogen receptor degrader showed efficacy in advanced ER+/HER2– breast cancers, including patients with ESR1...
News
Chemotherapy meets its match against aggressive ER+/HER2– breast cancers
Ribociclib plus endocrine therapy resulted in high response rates and double progression-free survival over combo chemotherapy.
News
Potential cause of worse outcomes among Black breast cancer patients found
Tumor microenvironment of metastasis doorways predicted worse outcomes in Black women with residual ER+/HER2– cancer after neoadjuvant...
News
Subset of patients with melanoma have very low mortality risk
The authors were interested in identifying lesions that are currently diagnosed as melanoma but might lack the capacity for metastasis.
News
Chromosomal test may ID risk for sudden infant deaths
The study findings were limited by several factors, including the small sample size and the inability to conduct CMA analyses on parents or obtain...
News
They trusted their prenatal test. They didn’t know the industry is an unregulated ‘Wild West.’
As regulators stay on the sidelines, a growing industry expands its reach but leaves some pregnant patients feeling misled and heartbroken.
News
More evidence in utero exposure to antiseizure meds safe for children’s cognition
“This is another encouraging piece that’s showing these new drugs are safe with regard to cognition.”
News
Blame IBS on gravity intolerance?
The gravity hypothesis is provocative, “but the best thing about it is that it is testable.”
News
Study eyes sunscreens marketed to individuals with skin of color
The average number of allergens per product was 4.7, most commonly fragrance/botanicals, tocopherol, sodium benzoates/derivatives, and sorbitan...
Opinion
Telemedicine increases access to care and optimizes practice revenue
For today’s overburdened GI practices, telehealth can improve patient access to care, alleviate the clinician shortage with work-from-home options...